AQST — Aquestive Therapeutics, Inc. stock price, charts and financials

QT40Aquestive Therapeutics, Inc.

Aquestive Therapeutics, Inc. (NASDAQ: AQST) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
4.61
-0.05-1.07%
OverviewShort InterestFilings
AQSTQT40Aquestive Therapeutics, Inc.·NASDAQ
4.61-1.07%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 17, 20268-KCurrent report
Sep 16, 20264Statement of changes in beneficial ownership
Sep 11, 20264Statement of changes in beneficial ownership
Sep 10, 20264Statement of changes in beneficial ownership
Sep 09, 20264Statement of changes in beneficial ownership
Sep 08, 20264Statement of changes in beneficial ownership
Aug 18, 20264Statement of changes in beneficial ownership
Aug 17, 20264Statement of changes in beneficial ownership
Aug 11, 20268-KCurrent report
Aug 11, 202610-QQuarterly report
Aug 10, 20268-KCurrent report
Jul 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 17, 20264Statement of changes in beneficial ownership
Jul 09, 2026424B3Prospectus
Jul 08, 2026EFFECTNotice of effectiveness
Jun 26, 2026S-3Shelf registration statement
Jun 24, 20264Statement of changes in beneficial ownership
Jun 16, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 10, 20268-KCurrent report
#1 / 25 of 368
Page
▼
/ 15